Cure for depression?

Gyakuto

Senior Master
Researchers found that a single, carefully administered dose of psilocybin can produce rapid and sustained improvements in individuals with severe treatment-resistant depression, offering new hope when traditional therapies have failed.

The participants had tried at least five prior treatments without any improvement. Then, they received one 25-milligram dose of psilocybin alongside psychological support. Just three weeks after treatment, the changes were hard to deny. Nearly 70 percent of participants experienced a signification reduction in their symptoms, and 42 percent achieved complete remission.

The results indicated that the benefits lasted up to 3 months, suggesting one treatment could have long-term benefits. The treatment was well-tolerated with no serious adverse effects reported, underscoring its potential as a safe alternative for people with limited options.
 
Researchers found that a single, carefully administered dose of psilocybin can produce rapid and sustained improvements in individuals with severe treatment-resistant depression, offering new hope when traditional therapies have failed.

The participants had tried at least five prior treatments without any improvement. Then, they received one 25-milligram dose of psilocybin alongside psychological support. Just three weeks after treatment, the changes were hard to deny. Nearly 70 percent of participants experienced a signification reduction in their symptoms, and 42 percent achieved complete remission.

The results indicated that the benefits lasted up to 3 months, suggesting one treatment could have long-term benefits. The treatment was well-tolerated with no serious adverse effects reported, underscoring its potential as a safe alternative for people with limited options.
So, you will promote a hallucinogenic but worry about ground wheat?
 
Single dose? Wow that is interesting indeed.

Also interesting as 5-HT2A activation suppresses the other serotonin receptors, such as 5-HT1A with is the main normal target in depression, which is why 5-HT2A antagonists enhance SSRI drugs in depression. But I suppose this also indicates how heterogenous depressions are as well?! After all this was for treatment resistance depression, which is indicative of different mechanisms.

I wonder if the "direction" of neuroplastic changes, is effectively in the right direction in this case? Is it coincidental, or does this appear sponteanously as plasticity increases because of the depression itself - self healing??
 
Back
Top